These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 23860768

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.
    Gubareva LV, Sleeman K, Guo Z, Yang H, Hodges E, Davis CT, Baranovich T, Stevens J.
    J Infect Dis; 2017 Sep 15; 216(suppl_4):S566-S574. PubMed ID: 28934455
    [Abstract] [Full Text] [Related]

  • 3. Characterization of substitutions in the neuraminidase of A(H7N9) influenza viruses selected following serial passage in the presence of different neuraminidase inhibitors.
    Farrukee R, Butler J, Reading PC, Hurt AC.
    Antiviral Res; 2019 Aug 15; 168():68-75. PubMed ID: 31132385
    [Abstract] [Full Text] [Related]

  • 4. [Drug susceptibility of wild-type and mutant H7N9 neuraminidase to zanamivir and oseltamivir].
    Wei YN, Zhang C, Chen Q, Guo Y.
    Bing Du Xue Bao; 2014 Jul 15; 30(4):396-401. PubMed ID: 25272593
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity.
    Woods CJ, Malaisree M, Long B, McIntosh-Smith S, Mulholland AJ.
    Sci Rep; 2013 Dec 20; 3():3561. PubMed ID: 24356381
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
    Marjuki H, Mishin VP, Chesnokov AP, De La Cruz JA, Davis CT, Villanueva JM, Fry AM, Gubareva LV.
    J Virol; 2015 May 20; 89(10):5419-26. PubMed ID: 25740997
    [Abstract] [Full Text] [Related]

  • 12. Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.
    Pizzorno A, Bouhy X, Abed Y, Boivin G.
    J Infect Dis; 2011 Jan 01; 203(1):25-31. PubMed ID: 21148493
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016-2019.
    Tang J, Zhang SX, Zhang J, Li XY, Zhou JF, Zou SM, Bo H, Xin L, Yang L, Liu J, Huang WJ, Dong J, Wang DY.
    Virology; 2020 Oct 01; 549():77-84. PubMed ID: 32853849
    [Abstract] [Full Text] [Related]

  • 15. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.
    Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solórzano A, García-Sastre A, Palese P, Bouvier NM.
    Nat Commun; 2013 Oct 01; 4():2854. PubMed ID: 24326875
    [Abstract] [Full Text] [Related]

  • 16. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
    Choi WS, Jeong JH, Kwon JJ, Ahn SJ, Lloren KKS, Kwon HI, Chae HB, Hwang J, Kim MH, Kim CJ, Webby RJ, Govorkova EA, Choi YK, Baek YH, Song MS.
    J Virol; 2018 Jan 01; 92(1):. PubMed ID: 29046464
    [Abstract] [Full Text] [Related]

  • 17. Impact of the R292K Mutation on Influenza A (H7N9) Virus Resistance towards Peramivir: A Molecular Dynamics Perspective.
    Mtambo SE, Ugbaja SC, Kumalo HM.
    Molecules; 2022 Mar 02; 27(5):. PubMed ID: 35268746
    [Abstract] [Full Text] [Related]

  • 18. R292K substitution and drug susceptibility of influenza A(H7N9) viruses.
    Sleeman K, Guo Z, Barnes J, Shaw M, Stevens J, Gubareva LV.
    Emerg Infect Dis; 2013 Mar 02; 19(9):1521-4. PubMed ID: 23965618
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV, Trujillo AA, Okomo-Adhiambo M, Mishin VP, Deyde VM, Sleeman K, Nguyen HT, Sheu TG, Garten RJ, Shaw MW, Fry AM, Klimov AI.
    Antivir Ther; 2010 Mar 02; 15(8):1151-9. PubMed ID: 21149922
    [Abstract] [Full Text] [Related]

  • 20. The evolution and characterization of influenza A(H7N9) virus under the selective pressure of peramivir.
    Ge Y, Chi Y, Min X, Zhao K, Wu B, Wu T, Zhu X, Shi Z, Zhu F, Cui L.
    Virology; 2019 Oct 02; 536():58-67. PubMed ID: 31400550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.